Improving Diabetes Care Through Teamwork, Comprehensive Education, Tighter Goals, and Technology: Single-Center Data from Türkiye
PDF

Original Article

Improving Diabetes Care Through Teamwork, Comprehensive Education, Tighter Goals, and Technology: Single-Center Data from Türkiye

J Clin Res Pediatr Endocrinol 2026;18(1):48-57 DOI: 10.4274/jcrpe.galenos.2025.2025-1-7
, , , , ,
PDF
Permissions

Abstract

Objective

The management of type 1 diabetes (T1D) in children aims to achieve an hemoglobin A1c (HbA1c) of <7%, a good quality of life and a life similar to that of their peers. While the HbA1c <7% target may be difficult to achieve, it is possible that national programs, quality control programs and setting team targets can achieve significant reductions in HbA1c.

Methods

The records of children with T1D followed up in our department between 2020 and 2022 were analyzed. Children and their families received a comprehensive education including an “Individual Treatment Plan”, nutrition and carbohydrate counting. All HbA1c measured during follow-up were averaged for each child separately. Continuous glucose monitoring (CGM) data from the last visit was evaluated in terms of achieving CGM consensus targets. To assess the effect of CGM use and automated insulin delivery (AID) system use, subjects were divided into 3 groups as multiple dose insulin and CGM users, non-AID pump users and AID users and evaluated.

Results

The 480 children included in the study had a mean HbA1c of 7.8±1.5% at the first visit. The median HbA1c value during the two-year follow-up was 7.1%. Of the participants, 43% had an HbA1c <7%. Evaluating cases by treatment modalities and glucose measurement methods revealed that AID users having the lowest mean HbA1c (7±0.7%).

Conclusion

While diabetes technologies have significantly improved T1D treatment, we believe that holistic approaches focusing on patient behaviors, comprehensive education, teamwork, written individualized treatment plans, and tighter metabolic goals are effective in achieving better glycemic outcomes.

Keywords: Carbohydrate counting, diabetes technologies, individual treatment plan, type 1 diabetes

Graphical Abstract

Read the full text

5 sections · 2 figures · 4 tables · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

American Diabetes Association Professional Practice Committee. 14. Children and adolescents: standards of care in diabetes-2024. Diabetes Care. 2024;47:S258-S281.

2

de Bock M, Codner E, Craig ME, Huynh T, Maahs DM, Mahmud FH, Marcovecchio L, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022;23:1270-1276.

3

Anderzén J, Hermann JM, Samuelsson U, Charalampopoulos D, Svensson J, Skrivarhaug T, Fröhlich-Reiterer E, Maahs DM, Akesson K, Kapellen T, Fritsch M, Birkebaek NH, Drivvoll AK, Miller K, Stephenson T, Hofer SE, Fredheim S, Kummernes SJ, Foster N, Amin R, Hilgard D, Rami-Merhar B, Dahl-Jørgensen K, Clements M, Hanas R, Holl RW, Warner JT. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study. Pediatr Diabetes. 2020;21:621-627. Epub 2020 Apr 14

4

Sandy JL, Tittel SR, Rompicherla S, Karges B, James S, Rioles N, Zimmerman AG, Fröhlich-Reiterer E, Maahs DM, Lanzinger S, Craig ME, Ebekozien O; Australasian Diabetes Data Network (ADDN); T1D Exchanged Quality Improvement Collaborative (T1DX-QI); Prospective Diabetes Follow-up Registry Initiative (DPV). Demographic, clinical, management, and outcome characteristics of 8,004 young children with type 1 diabetes. Diabetes Care. 2024;47:660-667.

5

Dovc K, Telic SS, Lusa L, Bratanic N, Zerjav-Tansek M, Kotnik P, Stefanija MA, Battelino T, Bratina N. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther. 2014;16:33-40. Epub 2013 Oct 16

6

Phelan H, King B, Anderson D, Crock P, Lopez P, Smart C. Young children with type 1 diabetes can achieve glycemic targets without hypoglycemia: results of a novel intensive diabetes management program. Pediatr Diabetes. 2018;19:769-775. Epub 2018 Mar 4

7

Albanese-O’Neill A, Grimsmann JM, Svensson AM, Miller KM, Raile K, Akesson K, Calhoun P, Biesenbach B, Eeg-Olofsson K, Holl RW, Maahs DM, Hanas R. Changes in HbA1c between 2011 and 2017 in Germany/Austria, Sweden, and the United States: a lifespan perspective. Diabetes Technol Ther. 2022;24:32-41. Epub 2021 Oct 11

8

Bratke H, Biringer E, Ushakova A, Margeirsdottir HD, Kummernes SJ, Njølstad PR, Skrivarhaug T. Ten years of improving glycemic control in pediatric diabetes care: data from the Norwegian childhood diabetes registry. Diabetes Care. 2024;47:1122-1130.

9

Prahalad P, Ding VY, Zaharieva DP, Addala A, Johari R, Scheinker D, Desai M, Hood K, Maahs DM. Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: the pilot 4T study. J Clin Endocrinol Metab. 2022;107:998-1008.

10

Zaharieva DP, Bishop FK, Maahs DM; 4T Study Research Team. Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes. Curr Opin Pediatr. 2022;34:423-429.

11

Simsek DG, Aycan Z, Özen S, Cetinkaya S, Kara C, Abalı S, Demir K, Tunç O, Uçaktürk A, Asar G, Baş F, Cetinkaya E, Aydın M, Karagüzel G, Orbak Z, Sıklar Z, Altıncık A, Ökten A, Özkan B, Ocal G, Semiz S, Arslanoğlu İ, Evliyaoğlu O, Bundak R, Darcan Ş. Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. J Clin Res Pediatr Endocrinol. 2013;5:20-26. Epub 2013 Feb 19

12

Hatun Ş, Demirbilek H, Darcan Ş, Yüksel A, Binay C, Şimşek DG, Kara C, Çetinkaya E, Ünüvar T, Uçaktürk A, Tütüncüler F, Cesur Y, Bundak R, Sağlam H, Şimşek E, Bereket A; Turkish Pediatric Diabetes Research Group. Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: a nationwide cross-sectional study. Diabetes Res Clin Pract. 2016;119:32-40. Epub 2016 Jun 27

13

Şahin NM, Child and adolescent type 1 diabetes cohort study in Turkey 2018-2023 data. 3rd Child and Adolescent Diabetes Symposium, 2023. Available from: www.uceds2023.org

14

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593-1603. Epub 2019 Jun 8

15

Hatun Ş, Gökçe T, Can E, Eviz E, Karakuş KE, Smart C, Hanas R, Yeşiltepe Mutlu G. Current management of type 1 diabetes in children: guideline-based expert opinions and recommendations. J Clin Res Pediatr Endocrinol. 2024;16:245-255. Epub 2024 Mar 15

16

Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H, Bjoerndalen H, de Beaufort C, Chiarelli F, Danne T, Schoenle EJ, Aman J; Hvidoere Study Group on Childhood Diabetes. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care. 2009;32:1384-1390. Epub 2009 May 12

17

Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O’Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44:254-280.

18

Arrieta A, Battelino T, Scaramuzza AE, Da Silva J, Castañeda J, Cordero TL, Shin J, Cohen O. Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: evidence from 12 870 real-world users. Diabetes Obes Metab. 2022;24:1370-1379. Epub 2022 May 12

19

Castañeda J, Arrieta A, van den Heuvel T, Battelino T, Cohen O. Time in tight glucose range in type 1 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G system. Diabetes Care. 2024;47:790-797.

20

Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022;65:604-619. Epub 2022 Feb 9

21

Hásková A, Radovnická L, Petruželková L, Parkin CG, Grunberger G, Horová E, Navrátilová V, Kádě O, Matoulek M, Prázný M, Šoupal J. Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: the CORRIDA randomized controlled trial. Diabetes Care. 2020;43:2744-2750. Epub 2020 Aug 28

22

Corathers SD, DeSalvo DJ. Therapeutic inertia in pediatric diabetes: challenges to and strategies for overcoming acceptance of the status quo. Diabetes Spectr. 2020;33:22-30.

23

Šumník Z, Pavlíková M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Čížek J, Strnadel J, Průhová Š, Cinek O; ČENDA Project Group. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: population data from the ČENDA registry. Pediatr Diabetes. 2021;22:439-447. Epub 2021 Feb 17

24

Addala A, Ding V, Zaharieva DP, Bishop FK, Adams AS, King AC, Johari R, Scheinker D, Hood KK, Desai M, Maahs DM, Prahalad P; Teamwork, Targets, Technology, and Tight Control (4T) Study Group. Disparities in hemoglobin A1c levels in the first year after diagnosis among youths with type 1 diabetes offered continuous glucose monitoring. JAMA Netw Open. 2023;6:e238881.

25

Campbell MD, West DJ, O’Mahoney LL, Pearson S, Kietsiriroje N, Holmes M, Ajjan RA. The relative contribution of diurnal and nocturnal glucose exposures to HbA1c in type 1 diabetes males: a pooled analysis. J Diabetes Metab Disord. 2022;21:573-581.

26

Alonso GT, Fink K, Maffeis C, Jannet S, Sari KV, Elizabeth D, Przemysława JC, Yash P, Carmel S. Variation in nutrition education practices in SWEET pediatric diabetes centers-an international comparison. Pediatr Diabetes. 2021;22:215-220. Epub 2020 Dec 3

27

Cengiz E. Automated insulin delivery in children with type 1 diabetes. Endocrinol Metab Clin North Am. 2020;49:157-166.

28

Van Name MA, Hilliard ME, Boyle CT, Miller KM, DeSalvo DJ, Anderson BJ, Laffel LM, Woerner SE, DiMeglio LA, Tamborlane WV. Nighttime is the worst time: parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes. 2018;19:114-120. Epub 2017 Apr 21

29

Muradoğlu S, Yeşiltepe Mutlu G, Gökçe T, Can E, Hatun Ş. An evaluation of glucagon injection anxiety and its association with the fear of hypoglycemia among the parents of children with type 1 diabetes. J Clin Res Pediatr Endocrinol. 2021;13:285-292. Epub 2021 Jan 25